Renal · Year 2 · from Renal

Case 2: Gitelman Syndrome

Patient Presentation

Demographics: 22-year-old female

Chief Complaint: Muscle cramps and fatigue

History of Present Illness: The patient has experienced recurrent muscle cramps, fatigue, and occasional palpitations since adolescence. She was recently evaluated for hypertension but was found to have consistently low blood pressure. She craves salty foods. She denies diuretic use, vomiting, or diarrhea.

Family History:

  • Brother with similar symptoms and low potassium

Physical Examination:

  • Blood pressure: 98/62 mmHg
  • Heart rate: 72 bpm
  • General: Thin, healthy-appearing
  • Cardiovascular: Regular rhythm, no murmurs
  • Neurologic: Slight muscle weakness proximally
  • No edema

Workup and Results

Laboratory Studies:

  • Creatinine: 0.8 mg/dL
  • Potassium: 2.8 mEq/L (low)
  • Magnesium: 1.2 mg/dL (low)
  • Bicarbonate: 32 mEq/L (elevated - metabolic alkalosis)
  • Chloride: 94 mEq/L
  • Calcium: 9.4 mg/dL
  • 24-hour urine calcium: 45 mg/day (low - hypocalciuria)
  • Urine potassium: 45 mEq/day (inappropriately high)
  • Plasma renin activity: Elevated
  • Aldosterone: Elevated

Genetic Testing:

  • SLC12A3 gene mutation (thiazide-sensitive NaCl cotransporter)

Clinical Image

Diagram illustrating the distal convoluted tubule showing the NCC (thiazide-sensitive sodium-chloride cotransporter) affected in Gitelman syndrome, with the resulting electrolyte abnormalities.

Diagnosis

Gitelman Syndrome

Diagnostic criteria met:

  • Hypokalemia with renal potassium wasting
  • Metabolic alkalosis
  • Hypomagnesemia
  • Hypocalciuria (key distinguishing feature from Bartter)
  • Genetic confirmation

Discussion

This case demonstrates Gitelman syndrome:

  • Mimics Chronic Thiazide Use: The lecture describes how Gitelman syndrome mimics chronic thiazide diuretic use because it results from loss-of-function mutations in the NCC transporter in the distal convoluted tubule.
  • Distinguishing from Bartter: The lecture emphasizes that hypocalciuria and hypomagnesemia distinguish Gitelman from Bartter syndrome. Bartter mimics loop diuretics and causes hypercalciuria.
  • Electrolyte Pattern: Both syndromes produce hypokalemia and metabolic alkalosis, but Gitelman is typically milder and presents later in life.
  • Compensation: Elevated renin and aldosterone represent appropriate physiologic response to volume contraction, not primary hyperaldosteronism.

Treatment Plan

  1. Potassium Supplementation:
  • Potassium chloride 40-80 mEq/day in divided doses
  • Target potassium >3.0 mEq/L
  1. Magnesium Supplementation:
  • Magnesium oxide or chloride supplements
  • Essential for correcting hypokalemia
  1. Consider Potassium-Sparing Diuretics:
  • Amiloride or spironolactone
  • Block distal potassium secretion
  1. Dietary Modifications:
  • High-salt diet (no restriction)
  • Potassium-rich foods
  1. Monitoring:
  • Regular electrolyte monitoring
  • Counsel about symptoms of severe hypokalemia

Teaching Points

  1. Gitelman mimics chronic thiazide use (DCT defect)
  2. Bartter mimics chronic loop diuretic use (TAL defect)
  3. Hypocalciuria distinguishes Gitelman from Bartter
  4. Hypomagnesemia is characteristic of Gitelman syndrome
  5. Treatment focuses on electrolyte replacement

All cases for this lecture as Markdown